RPG Life Sciences Limited Share Price & Analysis
Price Chart
Fundamentals
Strengths
- Strong return on equity (ROE 19.3%)
- Efficient capital deployment (ROCE 25.7%)
- Attractively valued vs sector (P/E 38.5x vs industry 54.7x)
- Virtually debt-free
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
RPGLIFE · as of Mar 2026
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 72.82% | 72.82% | 72.82% | 72.82% | 72.95% | 72.95% |
| FII | 0.56% | 0.90% | 1.15% | 1.35% | 1.30% | 1.46% |
| DII | 1.77% | 2.16% | 2.61% | 5.45% | 6.06% | 6.14% |
| Public | 24.85% | 24.12% | 23.44% | 20.40% | 19.70% | 19.46% |
Latest News
All newsRPG Life Sciences sees spurt in trading volume
*RPG Life Sciences sees spurt in trading volume* — RPG Life Sciences witnessed a significant spike in trading volume, prompting the NSE to seek clarification. The company has responded to the exchange's query to ensure transparency. No major corporate event was disclosed, suggesting the surge may be speculative. 📊 *STOCKS:* RPGLIFE | 🏢 *SECTOR:* Pharma | #LOWIMPACT #VolumeSpurt
RPG Life Sciences launches Naprosyn ES in India
*RPG Life Sciences launches Naprosyn ES in India.* The company has introduced Naprosyn ES, an enhanced-release formulation of naproxen, targeting chronic pain conditions. This launch expands its presence in the anti-inflammatory segment. The product is expected to contribute to revenue growth in the coming quarters. 📊 *STOCKS:* RPGLIFE | 🏢 *SECTOR:* Pharma | #MEDIUMIMPACT #ProductLaunch
RPG Life Sciences hosts investor meet with no major announcements
*RPG Life Sciences hosts investor meet with no major announcements.* The company shared updates during its recent analyst and institutional investor meet, with recording available online. No new financial guidance or strategic shifts were announced. The event served as a routine update for stakeholders. 📊 *STOCKS:* $RPGLIFE | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Invest0rMeet
RPG Life Sciences hosts investor meet with no major announcements
*RPG Life Sciences hosts investor meet with no major announcements.* The company provided updates during an analyst and institutional investor call, discussing business performance and strategy. No significant financial revisions or new developments were disclosed. Details remain in line with prior guidance. 📊 *STOCKS:* $RPGLIFE | 🏢 *SECTOR:* Pharma | #LOWIMPACT #InvestorMeet
RPG Life Sciences to host analyst meet
*RPG Life Sciences to host analyst meet*. The company will engage with analysts and institutional investors to discuss business updates. This event follows SEBI's disclosure norms for listed entities. No financial figures or strategic announcements were disclosed. 📊 *STOCKS:* $RPGLIFE | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Corporate
RPG Life Sciences opens special window for share transfer
*RPG Life Sciences opens special window for share transfer.* A special window has been opened for shareholders to submit requests for transfer and dematerialization of shares. The move follows a newspaper publication as part of regulatory compliance. **No financial impact** is expected from this procedural step. 📊 *STOCKS:* $RPGLIFE | 🏢 *SECTOR:* Pharma | #LOWIMPACT #CorporateAction
RPG Life Sciences publishes newspaper notice
*RPG Life Sciences publishes newspaper notice.* This is a routine corporate disclosure with no financial impact. Such notices are typically issued for regulatory or procedural compliance. No material business update was shared. 📊 *STOCKS:* $RPGLIFE | 🏢 *SECTOR:* Pharma | #LOWIMPACT #Notice